论文部分内容阅读
本文报告用等容量血液稀释治疗血细胞压积（Ｈｃｔ）明显增高所致的高粘血症患者１０３例，收到了较好的疗效。治疗前患者血液流变学指标较正常对照组明显增高，治疗后则大多数指标均有明显改善，尤以血细胞压积、全血低切粘度、全血高切粘度、聚集指数改善最为显著（Ｐ＜０．００１），部分患者血浆粘度也随之有所降低（Ｐ＜０．０１），而且血沉较治疗前明显增快：血气分析结果显示，血氧分压及血氧含量较治疗前明显提高（Ｐ＜０．００１，Ｐ＜０．０５）；治疗后大部分患者立即感到＂头脑清醒＂，头晕、头胀、头痛等主要症状可完全消失；高血压患者的血压也有明显下降（Ｐ＜０．００１），而对正常血压者影响不大。
This article reports the use of equal volume hemodilution hematocrit (Hct) was significantly higher in 103 patients with hyperviscosity, received a good effect. Before treatment, the indexes of hemorheology in patients were significantly higher than those in normal control group, and most of the indexes were significantly improved after treatment, especially in hematocrit, whole blood low-cut viscosity, whole-blood high-cut viscosity and aggregation index P <0.001). Some patients also had lower plasma viscosity (P <0.01), and ESR significantly increased compared with that before treatment. Blood gas analysis showed that partial pressure of oxygen and blood oxygen (P <0.001, P <0.05). Most of the patients felt sober immediately after treatment, the main symptoms of dizziness, bloating and headache completely disappeared, and the blood pressure of hypertensive patients also decreased significantly P <0.001), but no significant effect on normotensive patients.